within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01E_OtherCardiacPreparations.C01EB18_Ranolazine;

model Ranolazine
  extends Pharmacolibrary.Drugs.ATC.C.C01EB18;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C01EB18</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ranolazine is an antianginal medication, used primarily to treat chronic angina. It inhibits the late phase of the inward sodium current in cardiac myocytes, thereby reducing intracellular sodium and calcium overload. Ranolazine is approved and used in the management of stable angina pectoris (chronic angina) and may be used as adjunct therapy in patients not adequately controlled with other antianginal agents.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers (fasted state), following a single oral dose administration.</p><h4>References</h4><ol><li><p>Scoville, BA, et al., &amp; Mueller, BA (2019). Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis. <i>Renal failure</i> 41(1) 118–125. DOI:<a href=\"https://doi.org/10.1080/0886022X.2019.1585371\">10.1080/0886022X.2019.1585371</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30909832/\">https://pubmed.ncbi.nlm.nih.gov/30909832</a></p></li><li><p>Jerling, M (2006). Clinical pharmacokinetics of ranolazine. <i>Clinical pharmacokinetics</i> 45(5) 469–491. DOI:<a href=\"https://doi.org/10.2165/00003088-200645050-00003\">10.2165/00003088-200645050-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16640453/\">https://pubmed.ncbi.nlm.nih.gov/16640453</a></p></li><li><p>Mashayekhi-Sardoo, H, et al., &amp; Imenshahidi, M (2022). Diabetes mellitus aggravates ranolazine-induced ECG changes in rats. <i>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</i> 63(2) 379–388. DOI:<a href=\"https://doi.org/10.1007/s10840-021-01016-9\">10.1007/s10840-021-01016-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34155553/\">https://pubmed.ncbi.nlm.nih.gov/34155553</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Ranolazine;
